logo

Target Raises FY2026 Outlook After Q3 Beat; Prenetics Falls 42%, Ardent Prices $116 Million Offering, ChronoScale Lands $7.5 Billion AI Deal

Authored By HDFC SKY | Published at: Nov 19, 2026 08:55 AM IST

Target Raises FY2026 Outlook After Q3 Beat; Prenetics Falls 42%, Ardent Prices $116 Million Offering, ChronoScale Lands $7.5 Billion AI Deal

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Mumbai, 19 November 2026: US stocks saw mixed movements on November 18 as companies reported quarterly earnings, revised financial forecasts and announced major corporate developments. While Target, Amer Sports and other companies benefited from stronger results and growth outlooks, several stocks declined amid share offerings, debt financing plans and AI disruption concerns. Meanwhile, multiple companies announced share buyback programmes, adding to a varied session of corporate and market activity.

Target Raises FY2026 Outlook After Q3 Beat; Shares Gain 5.53% to $168.36

Target Corporation (NYSE: TGT) reported third-quarter fiscal 2026 earnings and revenue above analyst expectations on November 18, while raising its full-year sales guidance. The retailer posted adjusted earnings per share (EPS) of $2.65, beating the analyst consensus of $2.07 by $0.58. Revenue increased 7.1% year-over-year to $27.1 billion from $25.3 billion, exceeding market expectations of $26.5 billion.

Comparable sales grew 5.6% during the quarter, supported by a 5% increase in customer traffic. Digital comparable sales advanced 9.8%, while store comparable sales increased 4.6%. Among merchandise categories, Fun 101 sales rose nearly 27%, Beauty increased more than 9%, and Food and Beverage grew nearly 7%. Non-merchandise sales, including Roundel advertising revenue and Target Circle services, climbed nearly 20%.

However, the quarterly earnings included $0.50 per share in tariff refund benefits. Excluding these benefits, adjusted EPS would have increased 21% year-over-year. Gross margin expanded 2.3 percentage points to 30.5%, including a 1.1-percentage-point contribution from tariff refunds. Operating income margin improved to 6.2% from 3.8% in the year-ago quarter.

Target raised its fiscal 2026 net sales growth forecast to approximately 6%, an increase of one percentage point from its previous guidance. The company expects full-year EPS between $10.65 and $11.40, including approximately $2.14 in tariff refund benefits recognised to date. The guidance midpoint of $11.03 exceeds the analyst consensus of $10.55.

Target shares were trading at $168.36 as of 21:36:56 on November 18, up $8.83 or 5.53% from the previous close. The stock opened at $160.99 and recorded a high of $169.88 and a low of $159.95 during the session.

Lowe’s Raises FY2026 Sales Outlook; Shares Fall 1.25% To $217.71 After Q3 Results

Lowe’s Companies (NYSE: LOW) reported better-than-expected third-quarter fiscal 2026 earnings and revenue on November 18, supported by stronger comparable sales and online growth. However, its earnings included a significant benefit from tariff refunds, while declining margins and unchanged earnings guidance accompanied the results.

The home improvement retailer posted adjusted earnings of $3.10 per share, exceeding the Zacks Consensus Estimate of $2.86 by 8.4%. Revenue increased 9.3% year-over-year to $22.76 billion, surpassing analyst expectations of $22.4 billion. Comparable sales rose 1.8%, above the FactSet estimate of 0.4%, marking the company’s sixth consecutive quarter of positive comparable sales.

However, tariff refunds under the International Emergency Economic Powers Act contributed $0.34 per share to adjusted earnings, equivalent to approximately $250 million before taxes. Excluding this benefit, adjusted EPS would have been approximately $2.76. Gross margin declined to 32.95% from 34.19%, while operating margin fell to 11.32% from 11.92%. Online sales increased 17.4%, reflecting continued growth across the company’s digital and professional customer businesses.

Lowe’s raised its fiscal 2026 sales forecast to approximately $92.5 billion from $92 billion and increased its comparable sales outlook to flat to 0.5%. However, adjusted EPS guidance remained unchanged at approximately $12.25, while adjusted operating margin guidance was lowered to 11.5% from 11.6%.

Lowe’s shares were trading at $217.71 as of 10:52:49 AM EST on November 18, down $2.75 or 1.25% from the previous close of $220.46. The stock opened at $212.07 and recorded a high of $220.27 and a low of $211 during the session.

Elbit Systems Reports Record $33 Billion Backlog; Shares Decline 2.32% To $703.84

Elbit Systems (NASDAQ: ESLT) presented its third-quarter 2026 investor results on November 17, highlighting record order backlog, improved profitability and strong cash generation. The Israeli defence contractor reported revenue of $2.3 billion, up 17.2% from $1.9 billion in the corresponding quarter of 2025.

Non-GAAP operating profit increased 31% to $244 million, while GAAP operating income rose 36% to $232 million. Non-GAAP earnings per share (EPS) climbed 30% to $4.36, exceeding the analyst forecast of $3.65. GAAP EPS increased 32% to $3.70.

The company’s backlog expanded 31% year-over-year to a record $33 billion, adding $1 billion during the quarter. Free cash flow reached $276 million, compared with $101 million in Q3 2025, while operating cash flow surged 119% to $345 million.

Geographically, international markets accounted for 74% of the backlog, with Israel contributing the remaining 26%. European sales increased from $819 million in 2020 to $2.14 billion in 2025, while Asia-Pacific sales grew 29% over the same period to $1.244 billion.

Looking ahead, management projected high-teens revenue growth in 2027 compared with full-year 2026, alongside further margin expansion. Growth opportunities include land systems, electronic warfare, cyber solutions and autonomous technologies.

Elbit Systems shares were trading at $703.84 as of 10:46:37 AM EST, November 18, down $16.69 or 2.32% from the previous close of $720.53. The stock opened at $717.45 and recorded a high of $717.45 and a low of $702.34 during the session.

Also Read: What Is the New York Stock Exchange (NYSE)?

Prenetics Reports 3.3x Revenue Growth; Shares Plunge 42.07% As Loss Outlook Widens

Prenetics Global Limited (NASDAQ: PRE) reported third-quarter 2026 revenue above its guidance range on November 18, driven by rapid growth in its IM8 wellness brand. However, shares fell sharply as management increased its projected second-half adjusted EBITDA losses to $30-$35 million from the previously expected $8-$12 million.

Revenue reached $64.1 million, representing 38% sequential growth and approximately 3.3 times the year-ago level. IM8 contributed $62.9 million, up 39.8% from the previous quarter and approximately 3.7 times year-over-year. Gross margin remained at 64%, while Contribution Profit reached $30.6 million, representing a 48% margin.

Customer acquisition also showed improved efficiency. Prenetics added 137,892 customers during the quarter at a blended acquisition cost of $285, down 5% from $301 in Q2, despite increasing marketing expenditure by 10% to $39.3 million. The company reported a Q3 net loss of $25.4 million and adjusted EBITDA loss of $12.7 million.

Prenetics maintained its 2026 IM8 revenue guidance of $215-$222 million and projected revenue of at least $400 million for 2027. Its cash and current financial assets totalled $111.5 million at September 30, 2026.

Prenetics shares were trading at $9.46 as of 10:52:27 AM EST on November 18, down $6.87 or 42.07% from the previous close of $16.33. The stock opened at $13.89 and recorded a high of $14.28 and a low of $9.13 during the session.

Amer Sports Raises FY2026 Outlook After Q3 Beat; Shares Gain 0.63% To $30.43

Amer Sports, Inc. (NYSE: AS) reported better-than-expected third-quarter 2026 results on November 17, supported by double-digit revenue growth across all business segments and geographic regions. The sporting goods company posted adjusted earnings per share (EPS) of $0.42, exceeding analyst expectations of $0.27 by $0.15.

Revenue increased 24% year-over-year to $2.17 billion from $1.76 billion, representing 23% growth on a constant-currency basis. Technical Apparel revenue rose 26% to $861 million, driven by Arc’teryx. Outdoor Performance revenue increased 27% to $917 million, supported by Salomon Softgoods, while Ball & Racquet Sports revenue grew 12% to $391 million, led by Wilson Tennis 360.

Profitability also improved during the quarter. Adjusted operating margin expanded 70 basis points to 16.4%, while adjusted gross margin increased 150 basis points to 59.4%.

Amer Sports raised its full-year 2026 guidance, projecting adjusted EPS of $1.32-$1.35 and reported revenue growth of 25%-26%. The company also expects an adjusted operating margin of 14.5%-14.7%. Additionally, it authorized a $1 billion share repurchase programme, with plans to buy back up to $200 million in shares by December 31, 2026.

Amer Sports shares were trading at $30.43 as of 10:52:47 AM EST on November 18, up $0.19 or 0.63% from the previous close of $30.24. The stock opened at $30.05 and recorded a high of $31.02 and a low of $30 during the session.

Salesforce Shares Extend 9.45% Rout; Fall 3.06% To $188.56 Amid AI Disruption Fears

Salesforce Inc. (NYSE: CRM) shares continued declining on November 18, extending the previous session’s 9.45% plunge as investors reduced exposure to enterprise software stocks amid concerns about artificial intelligence (AI) disruption. Broader weakness across technology and application software companies also weighed on sentiment, with ServiceNow, HubSpot and Workday among the affected peers.

Investors are increasingly questioning whether autonomous AI agents could weaken Salesforce’s traditional per-user licensing model. Concerns about the company’s ability to generate revenue from its Agentforce platform, alongside cautious corporate technology spending, have added to uncertainty. Capital rotation ahead of Anthropic’s anticipated initial public offering has also contributed to pressure on established enterprise software companies.

Additional concerns emerged following reports of fresh workforce reductions across several Salesforce teams. Investors are also assessing the company’s acquisition and financing commitments, including its $5.7 billion agreement to acquire Braze and a $25 billion debt-funded share repurchase programme. S&P Global Ratings recently downgraded Salesforce’s credit rating from A+ to A.

Market attention is now turning to Salesforce’s third-quarter results, scheduled for December 2, 2026. Investors will monitor current remaining performance obligations (cRPO) and Agentforce revenue performance for indications of business momentum.

Salesforce shares were trading at $188.56 as of 10:52:53 AM EST on November 18, down $5.96 or 3.06% from the previous close of $194.52. The stock opened at $193.07 and recorded a high of $193.18 and a low of $186.84 during the session.

Synaptics Stockholders Approve onsemi Merger; Shares Edge Up 0.26% To $117.67

Synaptics Incorporated (NASDAQ: SYNA) announced on November 18 that stockholders approved its amended merger agreement with ON Semiconductor Corporation, known as onsemi. The agreement, dated October 1, 2026, provides for onsemi subsidiary Sonic Acquisition Corp. to merge with Synaptics, which will continue as a wholly owned subsidiary of onsemi. The transaction is expected to close in mid-2027, subject to the satisfaction or waiver of the agreement’s conditions.

The merger proposal received 31,209,141 votes in favour, representing 98.34% of votes cast, while 510,842 shares voted against and 14,723 abstained. Overall, holders of 31.73 million shares participated in the November 17 special meeting, representing 79.93% of the 39.70 million shares eligible to vote.

Stockholders also approved, on a non-binding advisory basis, compensation arrangements for named executive officers connected with the transaction. These include severance payments, accelerated equity-award vesting and annual bonus payments. The adjournment proposal was not presented because sufficient votes had already been secured for the merger.

Synaptics CEO Rahul Patel called the vote an important milestone and said the company remained focused on customers, employees and its work ahead.

Synaptics shares were trading at $117.67, up 0.26%, as of 12:43:10 p.m. EST on November 18, 2026. The stock opened at $117.54, compared with the previous close of $117.36, and recorded a high of $117.65 and a low of $117.20 during the session.

Also Read: How to invest in US stocks

Impact BioMedical Completes Zoar Merger; New Shares Debut Down 12.93% At $5.69

Impact BioMedical Inc. has completed its merger with Zoar Limited, becoming a wholly owned subsidiary of the Cayman Islands company, according to a statement filed with the US Securities and Exchange Commission. The transaction closed on November 16, with the combined company operating as PubCo.

Under the merger terms, each Impact BioMedical common share was converted into the right to receive one PubCo ordinary share following a 1-for-12.62 reverse stock split. Impact BioMedical shareholders received approximately 8.64 million PubCo shares, representing around 4.80% of the outstanding shares at closing. Kanans Visvanats, Zoar’s sole shareholder, holds approximately 94.02% of PubCo.

The new company’s ordinary shares began trading on NYSE American on November 18 under the ticker ZOAR. Trading in Impact BioMedical shares under IBO is being suspended, with delisting expected to take effect ten days after the SEC filing of Form 25. The company also intends to deregister its common stock and suspend its reporting obligations under the Exchange Act.

Outstanding Impact BioMedical options and warrants became fully vested at closing. Eligible in-the-money instruments were converted into shares, while those with exercise prices at or above the closing price were cancelled without consideration. The former board and certain executive officers resigned, with Visvanats becoming PubCo’s chairman and CEO.

Newly listed ZOAR shares traded at $5.69, down 12.93% from the $6.53 opening and previous close, as of 10:03:30 a.m. EST on November 18. The session high was $6.53 and the low was $5.69.

ChronoScale Secures $7.5 Billion AI Contract And $750 Million Funding; Shares Fall 7.65%

ChronoScale Holdings Corporation (NASDAQ: CHRN) has entered into a development partnership with STN, Inc. to build an artificial intelligence data centre in Odessa, Texas, while securing up to $750 million in financing. The planned facility will support AI infrastructure for a frontier AI laboratory, with an initial contract value of $7.5 billion over six years. The first deployment phase is scheduled for the first half of 2027.

The partnership will be equally owned by ChronoScale and STN, with each contributing $390 million in value for a 50% interest, subject to clearance under the Hart-Scott-Rodino Act. The agreement covers infrastructure capacity across three phases and represents approximately $20.8 million in annual revenue per megawatt on a blended basis.

The financing package comprises $250 million in equity and a convertible preferred facility of up to $500 million. The preferred facility has an initial minimum conversion price of $12 per share and can be drawn over four years, subject to customary conditions. ChronoScale expects to draw $10 million upon closing. Strategic investors participating include a frontier AI laboratory, Nutanix, Empery Digital Inc. and a storage infrastructure company.

The initial deployment includes 65 megawatts of capacity, while ChronoScale has a right of first offer on another 285 megawatts at the campus for potential future phases. The partnership and financing were expected to close on November 18, subject to closing conditions. Goldman Sachs is serving as exclusive capital markets adviser and lead placement agent, with Northland Capital Markets as co-placement agent.

ChronoScale shares traded at $9.00, down 7.65%, as of 10:52:18 a.m. EST on November 18, 2026. The stock opened at $9.69, compared with the previous close of $9.74. It reached a high of $9.75 and a low of $8.18 during the session.

Ardent Health Shares Fall 19.55% as 8 Million-Share Offering Priced at $14.50

Ardent Health, Inc. priced a secondary public offering of 8 million shares of its common stock at $14.50 each, according to a company press release. The shares are being sold by affiliates of Equity Group Investments and Ventas, Inc. Equity Group Investments is selling 7,136,719 shares, while Ventas is selling 863,281 shares.

The selling stockholders have granted the underwriters a 30-day option to buy up to an additional 1.2 million shares at the offering price, less underwriting discounts and commissions. The transaction is expected to close on Thursday, subject to customary closing conditions.

Separately, Ardent Health will repurchase 1.5 million shares from the underwriters at the same $14.50 per-share price paid to the selling stockholders. The company will fund the repurchase with existing cash. Ardent said the transaction is separate from its previously disclosed stock repurchase plan and will not reduce the remaining capacity under that plan. The underwriters will not receive compensation for the shares being repurchased.

Ardent is not selling shares in the offering and will not receive proceeds from the sales by the existing stockholders. Completion of the offering is not conditional on the share repurchase. J.P. Morgan and Barclays are the lead book-running managers. Several other financial institutions, including BofA Securities, Citigroup, Leerink Partners, Mizuho, RBC Capital Markets, Stephens Inc. and Truist Securities, are serving as bookrunners; Capital One Securities is co-manager. An SEC registration statement took effect on August 25, 2025.

Ardent Health shares were trading at $14.27 as of 1:34:46 p.m. EST on November 18, down $3.48, or 19.61%, from the previous close of $17.75. The stock opened at $13.75 and traded between $13.46 and $14.53 during the session.

Yesway Shares Fall 14.06% as Stockholders Launch 5 Million-Share Secondary Offering

Yesway, Inc. (NASDAQ: YSWY) announced that certain existing stockholders intend to sell 5 million shares of the company’s Class A common stock through an underwritten secondary public offering. The selling stockholders will receive all net proceeds from the transaction, and Yesway will not receive any proceeds from the share sale.

The underwriters have been granted a 30-day option to purchase up to an additional 750,000 shares from the selling stockholders at the public offering price, less underwriting discounts and commissions. Morgan Stanley is serving as the lead bookrunning manager for the offering.

The company has filed a registration statement on Form S-1 with the US Securities and Exchange Commission (SEC). However, the registration statement has not yet become effective. The securities cannot be sold, and offers to buy cannot be accepted, before the registration statement becomes effective. The proposed offering will be conducted through a prospectus in accordance with applicable securities regulations.

Established in 2015 and headquartered in Fort Worth, Texas, Yesway operates approximately 420 convenience stores across eight states in the Midwest and Southwest. Its retail operations include food service offerings, grocery products and private-label merchandise.

Yesway shares were trading at $20.85 as of 10:52:41 a.m. EST on November 18, down $3.41, or 14.06%, from the previous closing price of $24.26. The stock opened at $21.85 and recorded a high of $21.85 and a low of $20.19 during the session.

Also Read: US Stock Market Timings 

Hyster-Yale Shares Plunge 31.83% After $125 Million Convertible Notes Offering Plan

Hyster-Yale Inc. (NYSE: HY) shares declined sharply on Wednesday after the company announced plans to offer $125 million in convertible senior notes due 2031 through a private placement to qualified institutional buyers. The company has also granted initial purchasers an option to acquire up to an additional $18.75 million in notes.

Hyster-Yale intends to use the net proceeds, together with cash on hand, to repay $100 million of the $213.2 million outstanding under its term loan from the 2021 Credit Agreement. The company also plans to allocate up to $15 million to repurchase its Class A common stock concurrently with the notes pricing and fund capped call transactions. Any remaining proceeds will be used for general corporate purposes.

The notes will represent general senior unsecured obligations and carry interest payable semi-annually. Holders will have the right to convert the notes under specified circumstances. Hyster-Yale may settle conversions by paying cash up to the aggregate principal amount, with any excess conversion obligation settled in cash, Class A common stock or a combination of both.

The company expects to enter into capped call transactions designed to reduce potential dilution to its Class A common stock upon conversion of the notes. However, it cautioned that hedging activities by the option counterparties could affect the company’s share price and the pricing of the notes.

Hyster-Yale also plans to repay the remaining principal under its 2021 term loan on or before maturity using additional long-term debt on acceptable terms.

Hyster-Yale shares were trading at $17.84 as of 1:49:31 p.m. EST on November 18, down $8.36, or 31.83%, from the previous close of $26.20. The stock opened at $20.67 and recorded a high of $21.01 and a low of $16.68 during the session.

CVR Energy Shares Fall 10.62% as $1.25 Billion Notes Offering Targets Refinery Acquisition

CVR Energy, Inc. (NYSE: CVI) announced plans to offer $1.25 billion in senior secured notes due 2032 through a private placement. The company intends to use the proceeds, along with cash on hand and other financing transactions, to fund its previously announced acquisition of refineries in St. Paul Park, Minnesota, and Mandan, North Dakota, from subsidiaries of Marathon Petroleum Corporation and MPLX LP.

The funds will also support the redemption of CVR Energy’s outstanding 5.750% senior notes due 2028 and cover related fees and expenses. The company is also seeking a new $1.25 billion senior secured term loan B facility and plans to increase commitments under its existing asset-based revolving credit facility from $550 million to $1.1 billion.

The notes will initially be secured by an escrow account. If the acquisition is not completed by October 28, 2027, or the purchase agreement is terminated, CVR Energy must redeem the notes at 100% of their issue price plus accrued interest.

CVR Energy shares traded at $33.97 as of 2:04:05 p.m. EST on November 18, down $4.04, or 10.62%, from the previous close of $38.01. The stock opened at $37.66 and recorded a session high of $38.28 and a low of $34.98.

Applied Optoelectronics Shares Drop 11.57% as Company Launches $550 Million ATM Offering

Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares declined after the company disclosed a new at-the-market (ATM) equity offering programme of up to $550 million. The Texas-based optical networking company entered into an equity distribution agreement with Raymond James & Associates and Needham & Company, allowing it to sell common stock through Nasdaq and other trading venues.

The participating agents will receive a 2% commission on gross proceeds. Applied Optoelectronics is not obligated to sell shares and can suspend the programme at any time. Proceeds, if raised, will be used for general corporate purposes, potentially including debt repayment, working capital and manufacturing-related capital expenditures.

The announcement follows the completion of a previous $600 million ATM programme in early October, through which the company sold approximately 5.7 million shares and generated around $588 million in net proceeds. Applied Optoelectronics reported record third-quarter revenue of $269.9 million earlier this month, representing a 128% year-over-year increase.

Shares traded at $39.99 as of 2:06:36 p.m. EST on November 18, down $5.23, or 11.57%, from the previous close of $45.22. The stock opened at $41.28 and recorded a session high of $42.32 and a low of $37.60.

CSW Industrials Shares Rise 3.62% as Company Announces $300 Million Buyback Programme

CSW Industrials Inc. (NYSE: CSW) announced a new $300 million share repurchase programme on November 18, 2026, replacing its previous $250 million authorisation. The new programme will remain in effect until December 31, 2028, providing the company with an extended period to repurchase its outstanding shares.

The announcement reflects an expansion of the company’s existing share repurchase authorisation. CSW Industrials operates across three business segments: Contractor Solutions, Engineered Building Solutions and Specialized Reliability Solutions, supplying products for HVAC, refrigeration, plumbing and industrial applications.

CSW Industrials shares were trading at $279.15 as of 10:50:20 a.m. EST on November 18, up $9.76, or 3.62%, from the previous close of $269.38. The stock opened at $278.20 and recorded a high of $282.56 and a low of $273.07 during the session.

Modexus Solutions Authorizes $500 Million Share Buyback as Shares Trade 0.22% Lower

Modexus Solutions (NYSE: MOD) announced that its board of directors has authorized a share repurchase programme of up to $500 million in outstanding common stock. Effective immediately, the authorization has no expiration date and does not require the company to purchase a specific number of shares.

The company will determine the timing and volume of any repurchases based on business capital requirements, share price, trading volumes and broader market conditions. CEO Neil D. Brinker said the authorization reflects confidence in the company’s growth strategy and its commitment to shareholder returns.

Modexus Solutions shares traded at $129.45 as of 10:52:21 a.m. EST on November 18, down $0.28, or 0.22%, from the previous close of $129.73. The stock opened at $129.00 and recorded a session high of $134.58 and a low of $123.76.

Also Read: What Are Fractional Shares? 

Hesai Group Shares Rise 4.01% as Board Authorizes $100 Million Buyback Programme

Hesai Group (NASDAQ: HSAI; HKEX: 2525) announced that its board has authorized a share repurchase programme of up to $100 million covering its Class B ordinary shares and American depositary shares (ADSs). The programme will run for 12 months from November 18, 2026.

Repurchases may take place through open-market purchases, privately negotiated transactions, block trades or other permitted methods, including Rule 10b5-1 trading plans. The company plans to fund the purchases using existing cash and expects to cancel the repurchased shares to support earnings per share and long-term shareholder value. The board will periodically review the programme and may adjust its terms and size.

Hesai Group shares traded at $13.10 as of 10:52:36 a.m. EST on November 18, up $0.51, or 4.01%, from the previous close of $12.59. The stock opened at $13.57 and recorded a session high of $13.57 and a low of $12.98.

US stock market saw varied corporate developments, from earnings beats and raised forecasts to major financing plans and share offerings. While some stocks gained on positive business updates, others declined following capital-raising announcements or AI-related concerns. Several companies also unveiled buyback programmes.

Disclaimer

The information shared here is intended solely for informational and educational purposes and does not constitute investment recommendations. While we practice strict due diligence in curating daily market data, readers must perform independent research before trading. To flag any real-time data discrepancies or content concerns, please write to us at content@hdfcsec.com.

Summarize with AI
Google GeminiChatGPTPerplexity AIAnthropic AIGrok AI
Desktop BannerMobile Banner

Invest Anytime, Anywhere

Get it on Google PlayGet it on App Store

Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy